Stocks & ETFs Screener: 98 results (Pharmaceuticals)
| Symbol | Industry | Market Cap | Fund. Score | Div. Score | Tech. Score | P/E | Return 12m vs S&P 500 |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly |
Pharmaceuticals
Insulin, Diabetes, Oncology |
966B | 82.1% | 76.7% | 58.9% | 52.9 | 18.3% |
| JNJ Johnson & Johnson |
Pharmaceuticals
Pharmaceuticals, Devices, Lenses |
501B | 74.2% | 63.0% | 65.2% | 20.1 | 25.5% |
| ZEG AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
286B | 86.4% | 51.3% | 44.0% | 30.8 | 4.39% |
| AZN AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
285B | 79.5% | 46.7% | 55.7% | 30.5 | 20.0% |
| NVS Novartis |
Pharmaceuticals
Cardiovascular, Oncology |
266B | 91.8% | 61.5% | 70.0% | 19.0 | 25.0% |
| MRK Merck |
Pharmaceuticals
Oncology Vaccines Antimicrobials |
266B | 83.0% | 68.0% | 39.7% | 14.1 | -5.79% |
| NVO Novo Nordisk |
Pharmaceuticals
Insulin, Obesity, Growth, Blood |
234B | 89.3% | 46.2% | -49.0% | 14.3 | -48.0% |
| PFE Pfizer |
Pharmaceuticals
Medicines, Vaccines, Biosimilars |
142B | 57.4% | 78.4% | -8.79% | 14.6 | -14.2% |
| SNY Sanofi |
Pharmaceuticals
Vaccines, Immunology, Oncology |
118B | 61.7% | 59.8% | 8.88% | 15.8 | -11.6% |
| SAN Sanofi |
Pharmaceuticals
Vaccines, Oncology, Neurology |
116B | 75.3% | 69.8% | -18.6% | 15.6 | -22.9% |
| BMY Bristol-Myers |
Pharmaceuticals
Oncology, Immunotherapy |
111B | 73.3% | 81.4% | -7.0% | 18.4 | -15.4% |
| GSK GlaxoSmithKline |
Pharmaceuticals
Vaccines, Specialty Medicines |
99.1B | 76.9% | 24.1% | 76.8% | 13.6 | 29.0% |
| GS71 GSK |
Pharmaceuticals
Vaccines, Specialty Medicines |
98.5B | 80.1% | 34.9% | 52.1% | 13.7 | 11.8% |
| MRK Merck KGaA |
Pharmaceuticals
Reagents, Filtration, Antibodies |
62.6B | 61.9% | 65.8% | -25.6% | 18.0 | -25.6% |
| ZTS Zoetis |
Pharmaceuticals
Vaccines, Parasiticides |
56.0B | 83.4% | 74.1% | -53.5% | 21.3 | -33.6% |
| TAK Takeda |
Pharmaceuticals
Oncology, Gastroenterology |
52.1B | 62.5% | 37.3% | 54.4% | 224 | 4.30% |
| BAYN Bayer NA |
Pharmaceuticals
Pharmaceuticals, Consumer Health |
42.7B | 46.2% | 1.77% | 37.2% | - | 66.6% |
| TEVA Teva Pharma |
Pharmaceuticals
Generics, Respiratory, CNS |
36.6B | 53.0% | 17.4% | 65.0% | 52.3 | 22.9% |
| RPRX Royalty Pharma |
Pharmaceuticals
Royalties, Biopharma, Investments |
22.9B | 56.4% | 60.7% | 71.9% | 22.4 | 30.7% |
| VTRS Viatris |
Pharmaceuticals
Prescription, Generic, Biosimilar |
14.1B | 28.9% | 54.0% | 23.7% | - | -10.8% |
| RDY Dr. Reddy’s |
Pharmaceuticals
Generics, APIs, Biologics |
11.8B | 76.5% | 11.8% | -14.1% | 17.8 | -24.7% |
| IPN Ipsen |
Pharmaceuticals
Oncology, Neuroscience, Rare |
11.6B | 87.4% | 60.5% | 8.58% | 22.3 | -12.0% |
| ELAN Elanco Animal |
Pharmaceuticals
Parasiticides, Vaccines |
11.1B | 41.8% | - | 64.1% | 320 | 58.1% |
| JAZZ Jazz |
Pharmaceuticals
Xywav, Xyrem, Epidiolex, Rylaze |
10.3B | 51.2% | - | 48.2% | - | 18.3% |
| CORT Corcept |
Pharmaceuticals
Hyperglycemia, Cushings |
8.71B | 65.7% | - | -10.9% | 95.0 | -35.3% |
| AXSM Axsome Therapeutics |
Pharmaceuticals
Antidepressant, Wake-Promoting |
7.75B | 32.3% | - | 67.0% | - | 73.1% |
| TERN Terns |
Pharmaceuticals
Kinase Inhibitor, Thyroid Agonist |
4.61B | 34.7% | - | 62.2% | - | 498% |
| AMRX Amneal |
Pharmaceuticals
Generics, Injectables |
4.05B | 60.9% | - | 72.3% | - | 38.0% |
| TARS Tarsus |
Pharmaceuticals
Eye Therapy, Mite Blepharitis |
3.50B | 36.6% | - | 57.3% | - | 23.9% |
| VIRP Virbac |
Pharmaceuticals
Vaccines, Antibiotics |
3.46B | 85.5% | 58.9% | 34.1% | 22.2 | -5.85% |
| WVE Wave Life Sciences |
Pharmaceuticals
RNA Editing, GalNAc-Conjugated |
3.39B | 36.4% | - | 27.4% | - | 1.32% |
| LQDA Liquidia |
Pharmaceuticals
Dry Powder Injectable Liposomal |
3.11B | 27.4% | - | 63.5% | - | 120% |
| PBH Prestige Brand |
Pharmaceuticals
Analgesic, Diaper, Throat, Eye |
3.09B | 63.6% | 1.0% | -42.4% | 15.6 | -33.4% |
| SUPN Supernus |
Pharmaceuticals
ADHD, Epilepsy, Parkinson |
2.85B | 45.9% | - | 64.7% | - | 14.9% |
| BHC Bausch Health |
Pharmaceuticals
Gastroenterology, Dermatology |
2.66B | 51.3% | 3.14% | -17.4% | 7.40 | -23.2% |
| OCUL Ocular Therapeutix |
Pharmaceuticals
Dexamethasone, Axitinib, Travoprost |
2.59B | 31.9% | - | 40.2% | - | 14.4% |
| HRMY Harmony |
Pharmaceuticals
Wakix, Pitolisant, BP1.15205 |
2.17B | 91.9% | - | 9.90% | 11.9 | -9.22% |
| DMP Dermapharm Holding |
Pharmaceuticals
Branded Generics, OTC |
2.13B | 73.4% | 29.7% | 6.44% | 16.9 | -18.7% |
| AVDL Avadel |
Pharmaceuticals
Sodium Oxybate, Narcolepsy |
2.12B | 64.0% | - | 57.7% | - | 65.5% |
| MAZE Maze Therapeutics |
Pharmaceuticals
MZE829, MZE782, MZE001, Renal |
2.02B | 24.8% | - | 86.9% | - | 118% |
| PRGO Perrigo |
Pharmaceuticals
OTC, Vitamins, Infant Formula |
1.89B | 46.5% | 77.5% | -65.5% | - | -52.3% |
| OGN Organon |
Pharmaceuticals
Contraception, Fertility |
1.87B | 56.7% | 13.0% | -60.6% | 3.76 | -58.0% |
| ANIP ANI Pharmaceuticals |
Pharmaceuticals
Injectables, Softgels, Cortrophin |
1.85B | 68.5% | - | 44.2% | 51.4 | 19.7% |
| HROW Harrow Health |
Pharmaceuticals
Antibiotic, Steroid |
1.81B | 43.9% | - | 68.3% | - | 15.5% |
| TRVI Trevi Therapeutics |
Pharmaceuticals
Chronic Cough, Nalbuphine |
1.66B | 37.4% | - | 62.6% | - | 131% |
| INVA Innoviva |
Pharmaceuticals
Inhaled Combo, Vasoconstrictor |
1.66B | 80.7% | 1.25% | 34.4% | 13.4 | -3.41% |
| COLL Collegium |
Pharmaceuticals
Stimulant, Buccal, Opioid |
1.57B | 78.8% | - | 52.2% | 30.4 | 34.5% |
| PAHC Phibro Animal |
Pharmaceuticals
Antibacterials, Vaccines |
1.55B | 61.6% | 36.4% | 55.4% | 22.9 | 54.6% |
| EYPT Eyepoint |
Pharmaceuticals
Sustained Drug Implant, VEGF |
1.51B | 29.0% | - | 74.8% | - | 84.1% |
| EVT Evotec SE |
Pharmaceuticals
Oncology, Autoimmune, Metabolic |
1.49B | 22.2% | - | -67.2% | - | -43.9% |
| RAPP Rapport |
Pharmaceuticals
Epilepsy, Neuropathic Pain |
1.47B | 32.2% | - | 59.0% | - | 29.3% |
| AMLX Amylyx |
Pharmaceuticals
Avexitide, AMX0035, AMX0114, GLP-1 |
1.37B | 30.2% | - | 20.4% | - | 147% |
| SEPN Septerna, Common |
Pharmaceuticals
GPCR, Oral, Small-Molecule |
1.32B | 46.7% | - | 55.4% | - | 10.9% |
| PHAT Phathom |
Pharmaceuticals
Tablet, Antibiotic, Proton-Pump |
1.26B | 66.3% | - | 61.1% | - | 81.3% |
| AMPH Amphastar P |
Pharmaceuticals
Injectable, Inhalation |
1.25B | 76.4% | - | -13.6% | 11.9 | -38.5% |
| XERS Xeris |
Pharmaceuticals
Glucagon, Cortisol, Paralysis |
1.21B | 63.4% | - | 41.4% | - | 79.7% |
| PCRX Pacira BioSciences |
Pharmaceuticals
EXPAREL, ZILRETTA, Iovera |
1.19B | 62.3% | - | -2.14% | 56.4 | 12.9% |
| OMER Omeros |
Pharmaceuticals
Narsoplimab, OMS1029, Zaltenibart |
1.09B | 41.8% | - | 55.1% | - | 40.8% |
| CRON Cronos |
Pharmaceuticals
Dried Flower, Pre-Roll, Oil |
1.05B | 47.1% | - | 46.8% | 24.9 | 10.9% |
| TLRY Tilray |
Pharmaceuticals
Cannabis, Beverages, Wellness |
1.05B | 47.7% | - | -39.9% | - | -43.7% |
| ELVN Enliven |
Pharmaceuticals
Kinase Inhibitor, HER2 Inhibitor |
993M | 32.4% | - | -45.8% | - | -45.0% |
| CRMD CorMedix |
Pharmaceuticals
Antimicrobial, Catheter, Solution |
983M | 91.8% | - | 59.9% | 5.65 | 25.1% |
| TBPH Theravance |
Pharmaceuticals
COPD, Nebulizer, Norepinephrine |
949M | 51.0% | - | 79.7% | 32.9 | 65.4% |
| ARVN Arvinas |
Pharmaceuticals
Protac, Degrader, Breast |
893M | 39.9% | - | -7.29% | - | -48.6% |
| NKTR Nektar Therapeutics |
Pharmaceuticals
Autoimmune, Inflammation, Cancer |
869M | 32.5% | - | 50.6% | - | 155% |
| AQST Aquestive |
Pharmaceuticals
Buccal Film, Sublingual Film, Oral |
788M | 59.5% | - | 64.1% | - | 48.7% |
| NBY NovaBay |
Pharmaceuticals
Wound Cleanser, Hypochlorous Acid |
781M | 51.5% | 34.4% | 32.1% | 1.20 | 1,092% |
| FULC Fulcrum |
Pharmaceuticals
Pociredir, Losmapimod, Fetal |
746M | 23.1% | - | 47.9% | - | 90.8% |
| VTYX Ventyx Biosciences |
Pharmaceuticals
VTX958, Tamuzimod, VTX2735 |
644M | 35.3% | - | 52.1% | - | 232% |
| ANRO Alto Neuroscience |
Pharmaceuticals
Antidepressant, Cognitive |
573M | 44.2% | - | 50.3% | - | 220% |
| BIOA BioAge Labs |
Pharmaceuticals
Azelaprag, BGE-102, Obesity |
505M | 46.6% | - | 62.1% | 1.03 | 95.2% |
| CGC Canopy Growth |
Pharmaceuticals
Dried Flower, Extracts, Edibles |
483M | 17.5% | - | -48.5% | - | -65.1% |
| CTNM Contineum |
Pharmaceuticals
PIPE-791, PIPE-307, CTX-343 |
463M | 30.5% | - | -21.9% | - | -33.5% |
| ETON Eton |
Pharmaceuticals
Rare Disease Treatments, enal |
453M | 57.0% | - | 19.5% | - | -3.89% |
| SIGA SIGA Technologies |
Pharmaceuticals
Antiviral, Smallpox Treatment |
449M | 79.6% | 80.3% | 17.7% | 6.09 | -6.14% |
| EOLS Evolus |
Pharmaceuticals
Botulinum Toxin, Hyaluronic Acid |
444M | 28.9% | - | -51.1% | - | -48.8% |
| SNDL SNDL |
Pharmaceuticals
Cannabis, Alcohol, Retail, Flower |
427M | 50.9% | - | -38.2% | - | -22.5% |
| RLMD Relmada |
Pharmaceuticals
Gemcitabine, Docetaxel |
331M | 45.2% | - | 78.9% | - | 721% |
| ACRS Aclaris |
Pharmaceuticals
JAK Inhibitor, TSLP Antibody |
329M | 32.8% | - | 5.29% | - | -1.77% |
| NMRA Neumora |
Pharmaceuticals
Depression, Agitation, Alzheimer |
302M | 49.5% | - | -35.7% | - | -28.7% |
| AARD Aardvark |
Pharmaceuticals
ARD-101, ARD-201, Small-Molecule |
286M | 25.5% | - | -15.3% | - | -18.7% |
| AVIR Atea |
Pharmaceuticals
Antiviral, Oral, Hepatitis |
283M | 30.4% | - | 0.06% | - | -13.9% |
| ACB Aurora Cannabis |
Pharmaceuticals
Cannabis, Oils, Capsules, Edibles |
259M | 67.1% | - | -41.5% | - | -18.4% |
| MDWD Mediwound |
Pharmaceuticals
Burn Debridement, Chronic Wound |
241M | 20.3% | - | 14.8% | - | -13.4% |
| ALTS ALT5 Sigma |
Pharmaceuticals
Trading Platform, Payment Gateway |
239M | 27.8% | 1.0% | -62.2% | - | -80.1% |
| OGI OrganiGram Holdings |
Pharmaceuticals
Cannabis, Flower, Pre-Rolls |
229M | 20.8% | - | 8.38% | - | -11.9% |
| MIST Milestone |
Pharmaceuticals
Etripamil, Calcium Channel |
172M | 24.5% | - | -11.6% | - | -20.1% |
| SAVA Cassava Sciences |
Pharmaceuticals
Simufilam, SavaDx |
142M | 34.6% | 1.0% | -47.2% | - | -35.7% |
| ELTX Elicio Therapeutics |
Pharmaceuticals
Vaccine, Lymph Node, Preclinical |
139M | 45.7% | - | -1.48% | - | 32.5% |
| IRD Opus Genetics |
Pharmaceuticals
Gene Therapy, Retinal Diseases |
139M | 40.0% | - | 35.7% | - | 42.3% |
| CNTX Context |
Pharmaceuticals
Anti-Claudin6 Bispecific, T-Cell |
135M | 29.8% | - | 56.3% | - | 10.2% |
| VRCA Verrica |
Pharmaceuticals
Cantharidin, VP-102, VP-315 |
133M | 26.1% | - | 17.4% | - | -0.08% |
| SLGL Sol Gel |
Pharmaceuticals
Acne Cream, Rosacea Cream |
99.1M | 28.6% | - | 36.2% | - | 251% |
| SCLX Scilex Holding |
Pharmaceuticals
Lidocaine, Migraine, Anti-Gout |
96.2M | 67.5% | - | -43.5% | - | -27.4% |
| EVOK Evoke Pharma |
Pharmaceuticals
Nasal Spray, Diabetic Gastroparesis |
19.0M | 30.9% | - | 48.9% | - | 319% |
| ASBP Aspire BioPharma |
Pharmaceuticals
Sublingual Tablets, Aspirin |
18.3M | 39.1% | - | -70.2% | - | -99.0% |
| KALA Kala |
Pharmaceuticals
KPI-012, KPI-014, Eye Therapy |
6.97M | 25.4% | - | -66.3% | - | -93.2% |
| YCBD cbdMD |
Pharmaceuticals
CBD Tinctures, Gummies, Topicals |
6.58M | 15.4% | - | -41.6% | 1.45 | -70.4% |